Penman warns “self-styled disruptor” Cummings of “the realities of running government”
FDA General Secretary Dave Penman has responded to Dominic Cummings’ recent appointment as a chief advisor to Boris Johnson with a cautionary message: there is a difference between “theoretical radicalism” and the reality of government.
Speaking on this appointment, Penman said: “Dominic Cummings, like self-styled disruptors before him such as Steve Hilton, quickly find their theoretical radicalism clashes with the realities of running government and the complexities of delivering vital public services. There’s a huge difference between bringing in new ideas or radical agendas and implementing untested ideologies which, if they go wrong, will impact upon the delivery of public services to millions of citizens.”
Cummings, the former head of the Vote Leave campaign, has a history of criticising civil servants. He has described a permanent civil service as “an idea for the history books”, and stated that he would “get rid of permanent secretaries”.
Penman also noted the reason behind Johnson’s decision, explaining that “every new Prime Minister, impatient to see their bold agenda delivered, comes into office with a thirst to shake things up and think the unthinkable. The appointment of Dominic Cummings is clearly this Prime Minister’s signal of intent.”
The General Secretary’s warning extended to Johnson, as he noted that “ultimately, it will be for the Prime Minister and ministers to decide on the government’s agenda – with advice from the civil service and special advisers – as they will ultimately be accountable for any success or failure of any policy, including untested theoretical ones.”
Latest News from
Culture sector rescue package highlights failure of current funding models07/07/2020 12:25:00
The FDA represents staff working in museums and galleries across the UK.
Departure of Sir Mark Sedwill: FDA response29/06/2020 16:20:00
FDA General Secretary Dave Penman yesterday responded to the departure of Cabinet Secretary Sir Mark Sedwill.
FDA welcomes ‘historic moment for House of Commons’ as MPs put trust in independent process24/06/2020 16:20:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons debate on establishing the new Independent Expert Panel to deal with complaints of bullying and harassment against MPs.
Response to DFID and FCO merger17/06/2020 12:25:00
FDA National Officer Allan Sampson yesterday responded to the announcement that the Department for International Development (DFID) and the Foreign and Commonwealth Office (FCO) are to merge
HM Courts and Tribunals Service is failing to ensure safety, says FDA15/06/2020 13:15:00
As the recognised representatives of prosecutors and managers in the Crown Prosecution Service (CPS), the FDA has raised serious concerns with HM Courts and Tribunals Service (HMCTS) about its approach to reopening courts across England and Wales.
FDA secures pay rise for Welsh Government staff08/06/2020 14:25:00
FDA members in Welsh Government have voted to accept a 2.5% pay award for 2020, with a resounding 98% voting to accept the offer.
FDA and Prospect joint press release: Hybrid Parliament must continue01/06/2020 14:10:00
Last week the government refused to renew the standing order to continue with the hybrid Parliament and Jacob Rees-Mogg reassured the House that a risk assessment had been done.
FDA condemns “reckless” decision to return to physical Parliament21/05/2020 12:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to Leader of the House Jacob Rees-Mogg, who has made the decision that the government will not renew the standing orders for a hybrid Parliament.